These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8784885)

  • 21. Performance of DNA methylation-based biomarkers in the cervical cancer screening program of northern Portugal: A feasibility study.
    Salta S; Maia-Moço L; Estevão-Pereira H; Sequeira JP; Vieira R; Bartosch C; Petronilho S; Monteiro P; Sousa A; Baldaque I; Rodrigues J; Sousa H; Tavares F; Henrique R; Jerónimo C
    Int J Cancer; 2021 Dec; 149(11):1916-1925. PubMed ID: 34460099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New concepts on risk factors of HPV and novel screening strategies for cervical cancer precursors.
    Syrjänen K
    Eur J Gynaecol Oncol; 2008; 29(3):205-21. PubMed ID: 18592782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pap smear screening in women under 30 in the Norwegian Coordinated Cervical Cancer Screening Program, with a comparison of immediate biopsy vs Pap smear triage of moderate dysplasia.
    Nygård JF; Nygård M; Skare GB; Thoresen SO
    Acta Cytol; 2006; 50(3):295-302. PubMed ID: 16780024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost of screening and treatment of cervical dyskaryosis in Germany.
    Petry KU; Breugelmans JG; Bénard S; Lamure E; Littlewood KJ; Hillemanns P
    Eur J Gynaecol Oncol; 2008; 29(4):345-9. PubMed ID: 18714567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human papillomavirus infection in women with and without cervical cancer in Tbilisi, Georgia.
    Alibegashvili T; Clifford GM; Vaccarella S; Baidoshvili A; Gogiashvili L; Tsagareli Z; Kureli I; Snijders PJ; Heideman DA; van Kemenade FJ; Meijer CJ; Kordzaia D; Franceschi S
    Cancer Epidemiol; 2011 Oct; 35(5):465-70. PubMed ID: 21292583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-grade cervical abnormalities and cervical cancer in women following a negative Pap smear with and without an endocervical component: a cohort study with 10 years of follow-up.
    Sultana F; English DR; Simpson JA; Canfell K; Gertig DM; Saville M
    Int J Cancer; 2014 Sep; 135(5):1213-9. PubMed ID: 24488882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cervical intraepithelial neoplasia and aneusomy of TERC: assessment of liquid-based cytological preparations.
    Ramsaroop R; Oei P; Ng D; Kumar N; Cotter PD
    Diagn Cytopathol; 2009 Jun; 37(6):411-5. PubMed ID: 19191295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Some aspects of diagnosis and treatment of cervical intraepithelial neoplasia (review of the literature)].
    Jariene K; Cigriejiene V
    Medicina (Kaunas); 2002; 38(9):876-87; quiz 956. PubMed ID: 12474770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer.
    Hopman AH; Theelen W; Hommelberg PP; Kamps MA; Herrington CS; Morrison LE; Speel EJ; Smedts F; Ramaekers FC
    J Pathol; 2006 Dec; 210(4):412-9. PubMed ID: 17054308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA DOA1 and DOB1 loci in Honduran women with cervical dysplasia and invasive cervical carcinoma and their relationship to human papillomavirus infection.
    Ferrera A; Olivo A; Alaez C; Melchers WJ; Gorodezky C
    Hum Biol; 1999 Jun; 71(3):367-79. PubMed ID: 10380373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papilloma virus infection of uterine cervix and spectrum of cervical pathology in human immunodeficiency virus/AIDS.
    Jain BB; Adhikary T; Sadhukhan PC; Nandi A
    J Cancer Res Ther; 2021; 17(6):1462-1467. PubMed ID: 34916378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human telomerase RNA component (hTERC) gene expression and chromosome 7 ploidy correlate positively with histological grade of cervical intraepithelial neoplasia.
    Aggarwal D; Wadhwa N; Arora T; Rajaram S; Diwaker P; Halder A; Jain M; Mishra K
    Cytopathology; 2021 Sep; 32(5):631-639. PubMed ID: 33848025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia.
    Koushik A; Ghosh A; Duarte-Franco E; Forest P; Voyer H; Matlashewski G; Coutlée F; Franco EL;
    Cancer Detect Prev; 2005; 29(4):307-16. PubMed ID: 16122882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
    Sherman ME; Lorincz AT; Scott DR; Wacholder S; Castle PE; Glass AG; Mielzynska-Lohnas I; Rush BB; Schiffman M
    J Natl Cancer Inst; 2003 Jan; 95(1):46-52. PubMed ID: 12509400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Precancerous lesions of the uterine cervix: morphology and molecular pathology].
    Horn LC; Klostermann K
    Pathologe; 2011 Nov; 32 Suppl 2():242-54. PubMed ID: 21909794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cervix smear abnormalities: linking pathology data in female twins, their mothers and sisters.
    Vink JM; van Kemenade FJ; Meijer CJ; Casparie MK; Meijer GA; Boomsma DI
    Eur J Hum Genet; 2011 Jan; 19(1):108-11. PubMed ID: 20717168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,
    Bratti MC; Rodríguez AC; Schiffman M; Hildesheim A; Morales J; Alfaro M; Guillén D; Hutchinson M; Sherman ME; Eklund C; Schussler J; Buckland J; Morera LA; Cárdenas F; Barrantes M; Pérez E; Cox TJ; Burk RD; Herrero R
    Rev Panam Salud Publica; 2004 Feb; 15(2):75-89. PubMed ID: 15030652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of VEGF and TGF-beta1 mRNA in Pap smears correlates with progression of cervical intraepithelial neoplasia to cancer: implication of YY1 in cervical tumorigenesis and HPV infection.
    Baritaki S; Sifakis S; Huerta-Yepez S; Neonakis IK; Soufla G; Bonavida B; Spandidos DA
    Int J Oncol; 2007 Jul; 31(1):69-79. PubMed ID: 17549406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-vaccination epidemiology of human papillomavirus infections in Japanese women with abnormal cytology.
    Yamasaki K; Miura K; Shimada T; Ikemoto R; Miura S; Murakami M; Sameshima T; Fujishita A; Kotera K; Kinoshita A; Yoshiura K; Masuzaki H
    J Obstet Gynaecol Res; 2011 Nov; 37(11):1666-70. PubMed ID: 21793993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular pathogenesis of cervical cancer.
    Ibeanu OA
    Cancer Biol Ther; 2011 Feb; 11(3):295-306. PubMed ID: 21239888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.